David Damoiseaux

6PUBLICATIONS
4CO-AUTHORS
Molecular targetsPredictive and prognostic markersPsychosocial aspects of childbirth and perinatal mental healthModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 03, 2024
Early Prediction and Impact Assessment of CYP3A4-Related Drug-Drug Interactions for Small-Molecule Anticancer Drugs Using Human-CYP3A4-Transgenic Mouse Models.

David Damoiseaux, Jos H Beijnen, Alwin D R Huitema

|Dec 01, 2023
Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis.

David Damoiseaux, Alfred H Schinkel, Jos H Beijnen

|Oct 06, 2023
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk.

David Damoiseaux, Frédéric Amant, Jos H Beijnen

|Jun 23, 2023
Semi-physiological Enriched Population Pharmacokinetic Modelling to Predict the Effects of Pregnancy on the Pharmacokinetics of Cytotoxic Drugs.

J M Janssen, D Damoiseaux, J G C van Hasselt

|May 08, 2023
Predicting Chemotherapy Distribution into Breast Milk for Breastfeeding Women Using a Population Pharmacokinetic Approach.

David Damoiseaux, Daniel Centanni, Jos H Beijnen

|Jul 27, 2022
Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs.

David Damoiseaux, Wenlong Li, Alejandra Martínez-Chávez

Pageof 1

Frequent Collaborators

2 joint publications

Thomas P C Dorlo

1 joint publications

Alfred H Schinkel

1 joint publications

Gareth J Veal

1 joint publications

Jos H Beijnen